Heron Therapeutics (0J4V) Ownership - Who Owns Heron Therapeutics?
Heron Therapeutics (0J4V) Ownership Overview
- 5.64% Insiders
- 7.71% Mutual Funds
- 0.46% Other Institutional Investors
- 8.22% ETFs
- 77.97% Public Companies and Individual Investors
The ownership structure of Heron Therapeutics (GB:0J4V) stock is a mix of institutional, retail, and individual investors. Approximately 16.39% of the company’s stock is owned by Institutional Investors, 5.64% is owned by Insiders, and 77.97% is owned by Public Companies and Individual Investors.
The ownership structure of Heron Therapeutics (GB:0J4V) stock is a mix of institutional, retail, and individual investors. Approximately 16.39% of the company’s stock is owned by Institutional Investors, 5.64% is owned by Insiders, and 77.97% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
| Date | Name | Activity | Value |
|---|
Recent Hedge Fund Trading Activity
| Date | Firm | Activity | Value |
|---|
Top Shareholders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| BlackRock, Inc. | 10,550,750 | Institution | 5.56% | 2,985,862 |
| Vanguard | 8,946,213 | Institution | 4.71% | 2,531,778 |
| Adam Morgan | 8,877,027 | Insider | 4.68% | 2,512,199 |
| Vanguard Index Funds | 7,538,308 | Institution | 3.97% | 2,133,341 |
| Ishares | 5,472,145 | Institution | 2.88% | 1,548,617 |
| Fidelity Salem Street Trust | 1,825,815 | Institution | 0.96% | 516,706 |
| Fidelity Concord Street Trust | 1,425,725 | Institution | 0.75% | 403,480 |
| Vanguard Scottsdale Funds | 1,097,243 | Institution | 0.58% | 310,520 |
| Craig Collard | 866,929 | Insider | 0.46% | 245,341 |
| Invesco | 579,563 | Institution | 0.31% | 164,016 |
Top Mutual Fund Holders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| Vanguard Index Funds | 7,538,308 | Institution | 3.97% | 2,133,341 |
| Fidelity Salem Street Trust | 1,825,815 | Institution | 0.96% | 516,706 |
| Fidelity Concord Street Trust | 1,425,725 | Institution | 0.75% | 403,480 |
| Vanguard Scottsdale Funds | 1,097,243 | Institution | 0.58% | 310,520 |
| Vanguard World Fund | 477,861 | Institution | 0.25% | 135,235 |
| Goldman Sachs Trust | 427,637 | Institution | 0.23% | 121,021 |
| Schwab Capital Trust | 413,595 | Institution | 0.22% | 117,047 |
| Jacob Funds Inc. | 399,057 | Institution | 0.21% | 112,933 |
| Tiaa-cref Funds | 290,535 | Institution | 0.15% | 82,221 |
| Fidelity Commonwealth Trust Ii | 175,793 | Institution | 0.09% | 49,749 |
FAQ
Who Owns Heron Therapeutics (GB:0J4V)?
According to the latest TipRanks data, approximately 16.39% of the company's stock is held by institutional investors, 5.64% is held by insiders, and 77.97% is held by public companies and individual investors.
What percentage of Heron Therapeutics (GB:0J4V) stock is held by institutional investors?
According to the latest TipRanks data, approximately 16.39% of Heron Therapeutics (GB:0J4V) stock is held by institutional investors: 7.71% by mutual funds, 8.22% by ETFs and 0.46% by other institutional investors.
What percentage of Heron Therapeutics (GB:0J4V) stock is held by retail investors?
According to the latest TipRanks data, approximately 77.97% of Heron Therapeutics (GB:0J4V) stock is held by public companies and individual investors.
Who owns the most shares of Heron Therapeutics (GB:0J4V)?
BlackRock, Inc. owns the most shares of Heron Therapeutics (GB:0J4V).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
